Related Experiment Video
Updated: Aug 19, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Effects of Labetalol on Hemodynamics and Seizure Duration During ECT
W. Vaughn McCall1, Frank E. Shelp, Richard D. Weiner
1John Umstead Hospital, Butner, North Carolina, and Duke University Medical Center, Durham, North Carolina, USA.
Insights
Labetalol effectively reduces heart rate and rate pressure product during electroconvulsive therapy (ECT) in a dose-dependent manner. However, it did not significantly impact blood pressure or seizure duration in this study.
Area of Science:
- Anesthesiology
- Cardiology
- Neurology
Background:
- Beta blockers are frequently administered to manage heart rate and blood pressure surges during electroconvulsive therapy (ECT).
- Concerns exist regarding potential anticonvulsant effects of some beta blockers, which might interfere with ECT efficacy.
- Labetalol, a combined alpha and beta blocker, is commonly used in this context.
Purpose of the Study:
- To investigate the dose-response relationship of intravenous labetalol on hemodynamic responses and seizure duration during ECT.
- To evaluate the potential countertherapeutic effects of labetalol in ECT.
Main Methods:
- A randomized, double-blind, placebo-controlled study was conducted.
- Participants received varying doses of intravenous labetalol (5 mg, 10 mg) or placebo prior to ECT.
- Hemodynamic parameters (heart rate, blood pressure, rate pressure product) and seizure duration were monitored.
Main Results:
- Labetalol demonstrated a dose-dependent reduction in heart rate and rate pressure product at 5 mg and 10 mg compared to placebo.
- No significant differences in blood pressure or seizure duration were observed between labetalol groups and the placebo group.
- The 5 mg and 10 mg doses of labetalol did not show significant differences in their effects on the measured parameters.
Conclusions:
- Intravenous labetalol effectively attenuates heart rate and rate pressure product during ECT in a dose-dependent manner.
- Labetalol does not appear to significantly affect blood pressure or seizure duration in the tested dosage range.
- These findings suggest labetalol can be safely used for hemodynamic management during ECT without compromising seizure efficacy.
Abstract:
Beta blockers are commonly used to attenuate the transient increase in heart rate (HR) and blood pressure (BP) that accompany electroconvulsive therapy (ECT). Recent reports have suggested that several beta blockers have anticonvulsant properties and hence could be countertherapeutic with ECT. In a randomized, double-blind controlled study of the dose response effects of intravenous labetalol on ECT hemodynamics and seizure duration, labetalol exhibited dose-dependent reduction in HR and rate pressure product (RPP) at the 5 and 10 mg doses compared to placebo. However, no significant differences between labetalol 5 mg, 10 mg, or placebo were found on BP or seizure duration.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiopulmonary Resuscitation IV: Pharmacological Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electroconvulsive Therapy
Seizures l: Introduction

